Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial-Reference-Cited by-同舟云学术

Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial

Published:2020-02 Issue:2 Volume:31 Page:310-317
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mansfield A.S.,Każarnowicz A.,Karaseva N.,Sánchez A.,De Boer R.,Andric Z.,Reck M.,Atagi S.,Lee J.-S.,Garassino M.,Liu S.V.,Horn L.,Wen X.,Quach C.,Yu W.,Kabbinavar F.,Lam S.,Morris S.,Califano R.

Funder

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference10 articles.

1. Small cell lung cancer: where do we go from here?;Byers;Cancer,2015

2. Current standards for clinical management of small cell lung cancer;Farago;Transl Lung Cancer Res,2018

3. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N Engl J Med,2018

4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Small Cell Lung Cancer. V1,2019

5. Patient-reported outcomes in cancer drug development and US regulatory review: Perspectives from industry, the Food and Drug Administration, and the patient;Basch;JAMA Oncol,2015

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer;Cell & Bioscience;2024-09-12

2. The Trend of the Treatment of Advanced Hepatocellular Carcinoma: Combination of Immunotherapy and Targeted Therapy;Current Treatment Options in Oncology;2024-09-11

3. Advancements in Immunology and Microbiology Research: A Comprehensive Exploration of Key Areas;Microorganisms;2024-08-14

4. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27

5. Landscape and Treatment Options of Shapeshifting Small Cell Lung Cancer;Journal of Clinical Medicine;2024-05-26